Executive perspectives: Stephen Whitehead
Posted 19th March 2012 in Articles, General, Interviews | Register to comment
Continuing our series of Executive Perspectives, Paul Tunnah speaks to the Chief Exec of the UK’s major pharma industry association, the ABPI, for his views on where we are heading.
Following the launch of a new series earlier this year looking at perspectives from those leading organisations and companies, pharmaphorum managed to catch up with…
Read the full articleEffective discount tactics drive increased adherence and brand loyalty among patients and providers
Posted 16th March 2012 in Articles, General | Register to comment
Kelly Renfro explores how we can increase patient adherence in addition to brand loyalty with treatment discount tactics.
Even before some of the recent high profile patent expirations, the rate of generic drug use has continued to rise. In fact, recent reports…
Read the full articleTunnah’s musings: A little less conversation, a little more action please
Posted 15th March 2012 in Articles, General | Register to comment
Back with his regular monthly musings, Paul Tunnah wonders whether all this online noise might actually be stopping us doing some really important things.
The digital age has accomplished many good things. It’s connecting us in ways that were unthinkable just a few years ago and turning the world into…
Read the full articleBest practices in achieving sales force effectiveness
Posted 14th March 2012 in Articles, General, Interviews | Register to comment
We spoke with Mohamed Khater of Bayer HealthCare on sales force effectiveness and the implementation of a customer-centric approach.
Pharma and biotech companies are adjusting their sales force model in line with changing customer behaviour and a highly…
Read the full articleThe Internet, emerging data analytics and patient-reported outcomes: a new approach to pharmaceutical research and development
Posted 14th March 2012 in Articles, General | 1 comment
Carol Hills and Stephen Doogan address emerging data analytics and how they can help pharma to unleash real-world patient data.
Throughout the process of drug development and commercialisation, pharmaceutical companies use a variety of information sources to…
Read the full articlePhysician perspectives: Dr Kevin Pho
Posted 13th March 2012 in Articles, General, Interviews | Register to comment
We speak with Kevin Pho on social media use from the perspective of a physician.
Our latest ‘Physician perspective’ is that of Dr Kevin Pho, blogger at KevinMD.com. A leading physician voice and advocate of…
Read the full articleSuperhero Me! Winner of the eyeforpharma Mobile Health Competition 2012
Posted 12th March 2012 in Articles, General, Interviews | Register to comment
Rebecca Aris interviews Marianne Lynch and Dimuthu Jayawardana about their winning concept for a mobile app to help teenage cancer patients.
Smartphones and mobile devices have huge potential in terms of capability, but are often under-exploited. Through the increasing uptake of…
Read the full articleSocial pharma faces: Marc Monseau
Posted 9th March 2012 in Articles, General, Interviews | Register to comment
Our latest social pharma face is Marc Monseau who shares his insights on social media use in pharma.
In our latest “pharma social faces” pharmaphorum speaks with Marc Monseau who speaks from his experience from working within J&J…
Read the full articlemHealth Monthly Mashup: Release 9.0 – best practices for developing healthapps for the pharmaceutical industry (part 2)
Posted 9th March 2012 in Articles, General, Interviews | Register to comment
In the concluding part of our interview with J. Michael Smallwood, he offers advice to pharma on tapping into the mobile health space.
As our interview with J. Michael Smallwood continues we hear how agencies are uniquely positioned in…
Read the full articleBiosimilars 2012 – what does the current landscape look like?
Posted 8th March 2012 in Articles, Conferences, General | Register to comment
Rebecca Aris reports from the Biosimilars Congregation 2012 on the latest trends in this space.
Biologic treatments have revolutionised medicine and, following in their footsteps, biosimilars are set to continue the…
Read the full article